Select topic…AllAbout NRASApni Jung info for South Asian communityCommunityCOVID-19Diagnosis and MonitoringDiet and ExerciseEventsFamily PlanningFundraisingHealthcare professionalsOther ConditionsResearchSelf-managementSymptoms and CausesTreatmentWork and BenefitsSort byNewest – OldestOldest – Newest News, 05 Jul NRAS launch the #DoThe20Challenge to celebrate 20 years This challenge has now closed. Thank you to everyone who participated and helped raise funds! To celebrate our 20th Anniversary, we have launched #DoThe20Challenge, a fun way supporters can celebrate with us! There are a lot of ideas to get you started, anything that involves the number 20 – are you ready to take on the challenge? […] News, 21 Jan NICE offers hope for thousands who until now, potentially faced a life of disability and pain The National Institute for Health & Care Excellence (NICE) today released the Final Appraisal Document (FAD) on a new JAK inhibitor* filgotinib (Jyseleca) used in the treatment of Rheumatoid Arthritis (RA). NRAS warmly welcomes the fact that the FAD confirms that this drug will be available to not just to those most severely affected by […] News, 02 Jan NRAS report on the impact of living with active RA but not being able to access advanced therapies In 2020, NRAS conducted a survey amongst its members and non-members who had RA with a disease duration more than 2 years, who were not on advanced therapies (i.e. biologic/biosimilar or targeted synthetic DMARDs (JAK inhibitors)), with the aim of revealing the everyday impact of living with RA in people not treated with advanced therapies. It […] News, 14 Oct Review published in ‘Musculoskeletal Care’ with contribution from NRAS Just published in ‘Musculoskeletal Care’ – The Value, impact and role of nurses in rheumatology outpatient care: Critical review of the literature. 14/10/2020 Click here to read that review The Conclusion of this review: There is a convincing case to maintain and extend the role of nurses in managing RA, but further work is needed on […] News, 10 Mar EULAR issue new guidelines for the management of RA The European League Against Rheumatism (EULAR) have issued updated guidelines on the management of RA, which had previously been updated in 2016. News, 23 Jan Important Statement from NRAS about access to medicines For some time, NRAS has been concerned that some Clinical Commissioning Groups (CCGs) have been artificially restricting access to advanced therapies (biologics, biosimilars/JAK inhibitors) and undertook a Freedom of Information request to all CCGs about this. News, 04 Nov Congratulations to the Healthcare Champions of 2019 On 1st November, NRAS held its 6th Healthcare Champion awards ceremony in the magnificent surroundings of the Leathersellers’ Livery Hall in London. News, 11 Oct Shaping the Rheumatology Service in Scotland Scottish Quality Registry (ScotQR) for Rheumatoid Arthritis People with RA will be interested to know about a new initiative very soon to be trialled in two areas of Scotland, NHS Greater Glasgow and Clyde and NHS Lanarkshire. News, 11 Oct Early inflammatory arthritis patients waiting too long for specialist support A new report reveals that patients with suspected early inflammatory arthritis are waiting too long to see a specialist. News, 10 Oct Inflammatory arthritis patients face long delays for treatment, audit reveals A leading rheumatoid arthritis charity is warning that treatment delays for patients with suspected early inflammatory arthritis could result in unnecessary harm. National Rheumatoid Arthritis Society (NRAS) said that thousands of people who potentially have the condition aren’t getting treatment in line with NICE guidelines and Quality Standards, which risks life-long disabilities. Previous Page 1 … 8 9 10 11 12 Next Page
News, 05 Jul NRAS launch the #DoThe20Challenge to celebrate 20 years This challenge has now closed. Thank you to everyone who participated and helped raise funds! To celebrate our 20th Anniversary, we have launched #DoThe20Challenge, a fun way supporters can celebrate with us! There are a lot of ideas to get you started, anything that involves the number 20 – are you ready to take on the challenge? […]
News, 21 Jan NICE offers hope for thousands who until now, potentially faced a life of disability and pain The National Institute for Health & Care Excellence (NICE) today released the Final Appraisal Document (FAD) on a new JAK inhibitor* filgotinib (Jyseleca) used in the treatment of Rheumatoid Arthritis (RA). NRAS warmly welcomes the fact that the FAD confirms that this drug will be available to not just to those most severely affected by […]
News, 02 Jan NRAS report on the impact of living with active RA but not being able to access advanced therapies In 2020, NRAS conducted a survey amongst its members and non-members who had RA with a disease duration more than 2 years, who were not on advanced therapies (i.e. biologic/biosimilar or targeted synthetic DMARDs (JAK inhibitors)), with the aim of revealing the everyday impact of living with RA in people not treated with advanced therapies. It […]
News, 14 Oct Review published in ‘Musculoskeletal Care’ with contribution from NRAS Just published in ‘Musculoskeletal Care’ – The Value, impact and role of nurses in rheumatology outpatient care: Critical review of the literature. 14/10/2020 Click here to read that review The Conclusion of this review: There is a convincing case to maintain and extend the role of nurses in managing RA, but further work is needed on […]
News, 10 Mar EULAR issue new guidelines for the management of RA The European League Against Rheumatism (EULAR) have issued updated guidelines on the management of RA, which had previously been updated in 2016.
News, 23 Jan Important Statement from NRAS about access to medicines For some time, NRAS has been concerned that some Clinical Commissioning Groups (CCGs) have been artificially restricting access to advanced therapies (biologics, biosimilars/JAK inhibitors) and undertook a Freedom of Information request to all CCGs about this.
News, 04 Nov Congratulations to the Healthcare Champions of 2019 On 1st November, NRAS held its 6th Healthcare Champion awards ceremony in the magnificent surroundings of the Leathersellers’ Livery Hall in London.
News, 11 Oct Shaping the Rheumatology Service in Scotland Scottish Quality Registry (ScotQR) for Rheumatoid Arthritis People with RA will be interested to know about a new initiative very soon to be trialled in two areas of Scotland, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
News, 11 Oct Early inflammatory arthritis patients waiting too long for specialist support A new report reveals that patients with suspected early inflammatory arthritis are waiting too long to see a specialist.
News, 10 Oct Inflammatory arthritis patients face long delays for treatment, audit reveals A leading rheumatoid arthritis charity is warning that treatment delays for patients with suspected early inflammatory arthritis could result in unnecessary harm. National Rheumatoid Arthritis Society (NRAS) said that thousands of people who potentially have the condition aren’t getting treatment in line with NICE guidelines and Quality Standards, which risks life-long disabilities.
Stay up to date Sign up for all the latest RA and NRAS news and receive our regular monthly emails on the latest RA research, events and advice. Sign up